Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:13 p.m.

    📋 GILEAD SCIENCES, INC. (GILD) - Financial Results

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 16:05:51

    Event Type: Financial Results

    Event Details:

    Gilead Sciences Inc (GILD) Reports Q3 2022 Financial Results Gilead Sciences Inc (GILD) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 842
    • Net Income: 1985
    • EPS: 1.58
    • Cash and equivalents: 4739

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Costs And Expenses Interest Expense -256.00 -480.00 $224.00 +46.67%
    Costs And Expenses Total Other Income Expense -173.00 -395.00 $222.00 +56.20%
    Nongaap Total Other Income Expense 1.00 20.00 $-19.00 -95.00%
    Other Income Expense Net Reconciliation Total Other Income Expense 1.00 1.00 $0.00 +0.00%
    Assets Cash Equivalents Marketable Securities 7.00K 7.00K $0.00 +0.00%
    Assets Property Equipment Net 5.30K 5.12K $178.00 +3.48%
    Assets Intangible Assets Net 29.89K 33.45K $-3.57K -10.67%
    Assets Other Assets 5.67K 5.99K $-321.00 -5.36%
    Revenue 65.00 178.00 $-113.00 -63.48%
    Selling, General & Administrative 1.35K 2.44K $-1.09K -44.63%
    Interest Expense -256.00 -480.00 $224.00 +46.67%
    Net Loss 5.00 16.00 $-11.00 -68.75%
    Cash and Marketable Securities 7.83K 7.83K $0.00 +0.00%
    Intangible Assets, Net 33.45K 33.45K $0.00 +0.00%
    Other Assets 5.99K 5.99K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Gilead Sciences Inc
    • CIK: 0000882095
    • Ticker Symbol: GILD
    • Period End Date: 2022-08-02
    • Document Type: 8-K

Search

News categories